# Phase 3 Ischemic Stroke trials recruiting: 105 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 105 trials in phase 3 for Ischemic Stroke that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 3 Ischemic Stroke trials: 105 rows for $5.25, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 3 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-3/ischemic-stroke

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 105
- Recruiting or not yet: 105
- Read on: November 19, 2026

## Trials

The 25 newest of 105, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07944261 | Low-Dose Versus Standard-Dose Tenecteplase for Acute Minor Ischemic Stroke With Disabling Deficits | Shandong Provincial Hospital | Phase 3 | Recruiting | Acute Ischemic Stroke, Minor Ischemic Stroke | 1,324 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944261) |
| November 12, 2026 | NCT07931807 | Intravenous Thrombolysis, Endovascular Treatment, or Bridging Therapy for Medium Vessel Occlusion Stroke Within 24 Hours | The First Affiliated Hospital of University of Science and Technology of China | Phase 3 | Not yet recruiting | Medium Vessel Occlusion Stroke (MeVO), Acute Ischemic Stroke | 1,395 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931807) |
| November 3, 2026 | NCT07912970 | Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion... | Fujian Medical University Union Hospital | Phase 3 | Not yet recruiting | Acute Ischemic Stroke, Large Vessel Occlusion | 1,266 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07912970) |
| November 2, 2026 | NCT07908875 | Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack. | First Affiliated Hospital of Wannan Medical College | Phase 3 | Not yet recruiting | Ischemia Stroke, TIA (Transient Ischemic Attack) | 520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908875) |
| October 30, 2026 | NCT07906275 | INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | University of Calgary | Phase 3 | Not yet recruiting | Stroke, Acute Ischemic, Medium Vessel Occlusion | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07906275) |
| October 29, 2026 | NCT07902791 | Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Phase 3 | Recruiting | Acute Ischemic Stroke, Large Vessel Occlusion | 314 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07902791) |
| October 28, 2026 | NCT07901842 | Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 3 | Not yet recruiting | Acute Ischemic Stroke | 826 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901842) |
| October 27, 2026 | NCT07899307 | Metformin in Acute Ischemic Stroke | All India Institute of Medical Sciences | Phase 3 | Not yet recruiting | Acute Ischemic Stroke | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07899307) |
| October 15, 2026 | NCT07876492 | A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants | Regeneron Pharmaceuticals | Phase 3 | Not yet recruiting | Secondary Stroke | 6,106 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876492) |
| August 20, 2026 | NCT07776873 | Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke | The First Affiliated Hospital of Anhui Medical University | Phase 3 | Recruiting | Acute Ischemic Stroke | 616 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776873) |
| August 5, 2026 | NCT07748039 | Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events | Sponsor not shown (see the record) | Phase 3 | Recruiting | Acute Ischemic Stroke, Large Vessel Occlusion, Anterior Circulation Brain Infarction | 1,440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748039) |
| August 5, 2026 | NCT07746882 | Study on Anti-Thrombotic Regimens for Secondary Prevention in Ischemic Stroke Patients With Possible Benefit From Anticoagulation Therapy | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 3 | Not yet recruiting | Stroke, Acute Ischemic Stroke | 680 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07746882) |
| July 28, 2026 | NCT07730840 | Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke | Asan Medical Center | Phase 3 | Not yet recruiting | Ischemic Stroke, Transient Ischemic Attack | 984 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07730840) |
| July 27, 2026 | NCT07727395 | INtra-arterial AltEplase folloWing successfuL reperfusIoN After mEchanical Thrombectomy | 115 People's Hospital | Phase 3 | Recruiting | Stroke, Acute Ischemic, Large Vessel Occlusion, Thrombectomy | 416 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07727395) |
| July 7, 2026 | NCT07687706 | Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke) | Hanyang University Guri Hospital | Phase 3 | Recruiting | Ischemic Stroke, Ischemic Stroke, Acute, Transient Ischemic Attack (TIA), Cerebrovascular Disease, Gastrointestinal... | 1,524 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687706) |
| July 7, 2026 | NCT07687056 | ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 | University of Calgary | Phase 3 | Recruiting | Stroke, Acute Ischemic, Endovascular Thrombectomy, Acute Ischemic Stroke AIS | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687056) |
| June 26, 2026 | NCT07670065 | Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit | Beijing Tiantan Hospital | Phase 3 | Not yet recruiting | Acute Ischemic Stroke, Large Vessel Occlusion | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07670065) |
| June 25, 2026 | NCT07668323 | Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion | The First Affiliated Hospital with Nanjing Medical University | Phase 3 | Recruiting | Medium Vessel Occlusion, Ischemic Stroke, Acute | 372 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07668323) |
| June 12, 2026 | NCT07645586 | A Phase 3 Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke | Beijing Tiantan Hospital | Phase 3 | Not yet recruiting | Ischemic Stroke | 584 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07645586) |
| June 2, 2026 | NCT07621796 | Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant | Hackensack Meridian Health | Phase 3 | Not yet recruiting | Acute Ischemic Stroke | 660 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621796) |
| June 1, 2026 | NCT07617870 | Pro-urokinase for Extended-Window Posterior Circulation Stroke | The First Affiliated Hospital of Zhengzhou University | Phase 3 | Not yet recruiting | Acute Ischemic Stroke | 586 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07617870) |
| May 26, 2026 | NCT07606807 | rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 3 | Recruiting | Acute Ischemic Stroke | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07606807) |
| May 22, 2026 | NCT07603440 | Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A... | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | Stroke | 486 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07603440) |
| April 20, 2026 | NCT07540416 | Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR Mismatch | The First Affiliated Hospital of Zhengzhou University | Phase 3 | Recruiting | Acute Ischemic Stroke | 564 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07540416) |
| April 17, 2026 | NCT07537933 | Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial Large-Vessel Occlusion | Shandong Provincial Hospital | Phase 3 | Not yet recruiting | Acute Ischemic Stroke, Large-vessel Occlusion, Endovascular Treatment | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07537933) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Beijing Tiantan Hospital | 11 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 8 |
| Capital Medical University | 7 |
| Kafrelsheikh University | 5 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 5 |
| University of Calgary | 3 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Hospital Moinhos de Vento | 2 |
| Shandong Provincial Hospital | 2 |
| The First Affiliated Hospital of University of Science and Technology of China | 2 |
| First Affiliated Hospital of Wannan Medical College | 2 |
| Peking Union Medical College Hospital | 2 |
| Xuanwu Hospital, Beijing | 2 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 2 |
| Xinqiao Hospital of Chongqing | 2 |
| Yonsei University | 2 |
| The First Affiliated Hospital of Zhengzhou University | 2 |
| Southwest Hospital, China | 1 |
| Weifang Medical University | 1 |
| General Hospital of Shenyang Military Region | 1 |
| University Hospital, Bordeaux | 1 |
| [Shin Poong Pharmaceutical Co. Ltd.](https://specstream.ai/data/clinical-trials/company/shin-poong-pharmaceutical-co-ltd) | 1 |
| Sunnybrook Health Sciences Centre | 1 |
| Sichuan Provincial People's Hospital | 1 |
| Second Affiliated Hospital of Guangxi Medical University | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 56 |
| United States | 7 |
| Canada | 6 |
| Egypt | 5 |
| France | 5 |
| South Korea | 5 |
| Australia | 5 |
| Spain | 3 |
| Germany | 3 |
| Brazil | 2 |
| Norway | 2 |
| Russia | 2 |
| Vietnam | 2 |
| India | 2 |
| Denmark | 1 |
| Sweden | 1 |
| Argentina | 1 |
| Bulgaria | 1 |
| Greece | 1 |
| Hungary | 1 |
| Indonesia | 1 |
| Kazakhstan | 1 |
| Malaysia | 1 |
| Romania | 1 |
| Taiwan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Public adjusters in the United States](https://specstream.ai/data/businesses/public-adjusters/united-states)
- [3D printing companies in the United States](https://specstream.ai/data/businesses/3d-printing-companies/united-states)
- [Construction companies in the United States](https://specstream.ai/data/businesses/construction-companies/united-states)
- [Hotels in the United States](https://specstream.ai/data/businesses/hotels/united-states)
- [Plastic and reconstructive surgery practices in the United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/united-states)
- [Veterans hospitals in the United States](https://specstream.ai/data/businesses/veterans-hospitals/united-states)
